Total Payments
$10,125
2024 Payments
$790.15
Companies
43
Transactions
630
Medicare Patients
19,210
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$9,952 (98.3%)
Education$173.12 (1.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,952 | 618 | 98.3% |
| Education | $173.12 | 12 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,971 | 111 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,259 | 105 | $0 (2024) |
| Novo Nordisk Inc | $943.84 | 68 | $0 (2024) |
| Mylan Specialty L.P. | $897.77 | 53 | $0 (2024) |
| Insmed, Inc. | $890.72 | 50 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $638.96 | 38 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $583.99 | 37 | $0 (2021) |
| Philips Electronics North America Corporation | $491.67 | 19 | $0 (2022) |
| Amgen Inc. | $366.59 | 22 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $328.33 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $790.15 | 42 | AstraZeneca Pharmaceuticals LP ($242.63) |
| 2023 | $859.72 | 51 | AstraZeneca Pharmaceuticals LP ($213.60) |
| 2022 | $1,225 | 64 | Insmed, Inc. ($241.91) |
| 2021 | $1,460 | 89 | AstraZeneca Pharmaceuticals LP ($306.39) |
| 2020 | $1,696 | 98 | AstraZeneca Pharmaceuticals LP ($335.32) |
| 2019 | $1,906 | 139 | Sunovion Pharmaceuticals Inc. ($275.54) |
| 2018 | $1,074 | 71 | AstraZeneca Pharmaceuticals LP ($318.83) |
| 2017 | $1,113 | 76 | Mylan Specialty L.P. ($140.52) |
All Payment Transactions
630 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $0.95 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/06/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $0.22 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $45.90 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.37 | General |
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Respiratory | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $0.24 | General |
| Category: RESPIRATORY | ||||||
| 08/06/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/29/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $31.71 | General |
| Category: Respiratory | ||||||
| 07/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: RESPIRATORY | ||||||
| 06/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Gastroenterology | ||||||
| 06/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: RESPIRATORY | ||||||
| 06/05/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/04/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: Inflammation | ||||||
| 05/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 44 | 3,772 | 5,306 | $1.1M | $359,686 |
| 2022 | 58 | 4,547 | 7,016 | $990,236 | $345,275 |
| 2021 | 52 | 4,942 | 7,859 | $938,993 | $396,326 |
| 2020 | 55 | 5,949 | 9,324 | $1.2M | $481,695 |
Total Patients
19,210
Total Services
29,505
Medicare Billing
$1.6M
Procedure Codes
211
All Medicare Procedures & Services
211 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 404 | 1,022 | $127,750 | $84,945 | 66.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 347 | 706 | $70,600 | $43,043 | 61.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 88 | 88 | $61,600 | $24,622 | 40.0% |
| 95957 | Measurement of brain wave activity (eeg), digital analysis | Office | 2023 | 97 | 97 | $67,900 | $19,692 | 29.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 93 | 196 | $30,455 | $17,682 | 58.1% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 87 | 178 | $89,000 | $16,319 | 18.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 97 | 98 | $39,200 | $13,720 | 35.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 92 | 97 | $25,222 | $12,713 | 50.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 66 | 201 | $30,252 | $12,056 | 39.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 56 | 57 | $46,448 | $9,207 | 19.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 62 | 63 | $18,900 | $8,143 | 43.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 216 | 218 | $32,700 | $8,053 | 24.6% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 46 | 46 | $13,800 | $7,789 | 56.4% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 87 | 89 | $44,500 | $7,472 | 16.8% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 86 | 87 | $26,100 | $7,379 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $12,200 | $6,668 | 54.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 72 | 94 | $9,400 | $5,913 | 62.9% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 87 | 89 | $13,350 | $5,700 | 42.7% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 185 | 187 | $28,050 | $5,519 | 19.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 219 | 221 | $33,150 | $5,503 | 16.6% |
| 92653 | Evaluation of brain response to sound for diagnosis of nervous system disorders with interpretation and report | Office | 2023 | 72 | 72 | $36,000 | $4,571 | 12.7% |
| 95930 | Measurement of nerve conduction using visual stimulation testing with report | Office | 2023 | 71 | 71 | $35,500 | $3,467 | 9.8% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 105 | 105 | $4,200 | $3,267 | 77.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 100 | 100 | $3,000 | $2,893 | 96.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 16 | 72 | $7,200 | $2,561 | 35.6% |
About Dr. Ifediora Afulukwe, MD
Dr. Ifediora Afulukwe, MD is a Pulmonary Disease healthcare provider based in Heath Springs, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417912932.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ifediora Afulukwe, MD has received a total of $10,125 in payments from pharmaceutical and medical device companies, with $790.15 received in 2024. These payments were reported across 630 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($9,952).
As a Medicare-enrolled provider, Afulukwe has provided services to 19,210 Medicare beneficiaries, totaling 29,505 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 211 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Internal Medicine, Sleep Medicine
- Location Heath Springs, SC
- Active Since 04/18/2006
- Last Updated 12/21/2016
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1417912932
Products in Payments
- Arikayce (Drug) $890.72
- TRELEGY ELLIPTA (Drug) $810.88
- SYMBICORT (Drug) $565.07
- Ozempic (Drug) $493.25
- Yupelri (Drug) $468.60
- XIFAXAN (Drug) $414.12
- BREZTRI (Drug) $305.65
- FASENRA (Biological) $280.37
- FARXIGA (Drug) $278.00
- LONHALA MAGNAIR (Drug) $263.95
- JARDIANCE (Drug) $231.15
- YUPELRI (Drug) $229.71
- DUPIXENT (Biological) $208.75
- STIOLTO RESPIMAT (Drug) $190.65
- ANORO (Drug) $158.45
- Resp Care Undiv (Device) $153.73
- Wellcentive Undiv (Device) $149.97
- (8874) inCourage (Device) $146.94
- Prolia (Biological) $144.73
- CHANTIX (Drug) $142.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.